Advertisements



Blueprint data leaves "door wide open" for Loxo"s LOXO-292, says Stifel

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 16th, 2018

Loxo data not "transformational," but keeps inspiring confidence, says Stifel

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 26th, 2018

Blueprint sinks, Loxo rises after trial data on potential solid tumor treatment

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 16th, 2018

Loxo Oncology"s 292 remains on top after RET data updates, says Piper Jaffray

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 7th, 2018

Donald Trump Jr. leaves the door open for a possible run for office of his own: "I"m never going to rule anything out"

Mark Wilson/Getty Images Donald Trump Jr. left the door open to a future run for office. He has flirted with running for.....»»

Category: topSource: businessinsiderOct 5th, 2018

Loxo RET inhibitor still looks superior to Blueprint"s, says Piper Jaffray

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 26th, 2018

iPhone XS and XR: What Apple didn"t give us

With mostly incremental updates to the new iPhones, Apple leaves the door open for competitors to up the ante in the next 12 months......»»

Category: topSource: moneycentralSep 16th, 2018

Bayer open for drug licensing deals, cutting debt remains priority

Bayer is ready to spend money on more drug licensing agreements like last year's deal with Loxo Oncology but its priority is to reduce debt after the takeover of Monsanto......»»

Category: topSource: reutersSep 5th, 2018

Trump Today: Trump Today: President tells Congress he’s moving ahead with Mexico trade deal, leaves door open for Canada

President Donald Trump on Friday told Congress he intends to sign a trade agreement with Mexico, but left the door open for Canada to join, after talks between U.S. and Canadian officials wound down for the week......»»

Category: topSource: marketwatchAug 31st, 2018

Blueprint Medicines Vs. Loxo Oncology: A Head-To-Head Of Novel RET Inhibitors

Blueprint Medicines Vs. Loxo Oncology: A Head-To-Head Of Novel RET Inhibitors.....»»

Category: topSource: seekingalphaJun 19th, 2018

We just got a lot of updates on the state of cancer treatments — here are the winners and losers (BLUE, NKTR, LOXO, MRK, BMY)

Over the weekend at the American Society of Clinical Oncologists meeting, a lot of updates and new data were presented.  It sent stocks all over the place Monday with the biggest movers being Bristol-Myers Squibb, Nektar, Loxo and Bluebird bi.....»»

Category: topSource: businessinsiderJun 4th, 2018

Technical Take: Loxo Oncology at new life high after LOXO-292 data

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 4th, 2018

Loxo Oncology data came in "far above expectations," says JMP Securities

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 4th, 2018

Loxo"s 292 data was "unequivocally impRETssive," says Piper Jaffray

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 3rd, 2018

Loxo announces positive interim data from LOXO-292 dose escalation trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 3rd, 2018

The New York Post: Trump shrugs off efforts to protect his iPhones, report says — and that leaves door open to hackers

President Trump has rebuffed attempts to make his phones more secure because he claims it is “too inconvenient,” according to a Politco report......»»

Category: topSource: marketwatchMay 22nd, 2018

Your Daily Pharma Scoop: Loxo Outstanding Results, Cimzia Trial Success, Audentes Positive Data

Your Daily Pharma Scoop: Loxo Outstanding Results, Cimzia Trial Success, Audentes Positive Data.....»»

Category: topSource: seekingalphaMay 17th, 2018

Loxo Oncology shares surge 21% on preview of cancer drug trial data

Loxo Oncology Inc. shares surged 20.8% in heavy Thursday mo.....»»

Category: topSource: marketwatchMay 17th, 2018

Loxo Oncology shares surge nearly 20% on preview of cancer drug trial data

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchMay 17th, 2018

Loxo Oncology price target raised to $190 after ASCO abstracts at Stifel

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 17th, 2018

DOJ antitrust chief leaves door open to settlement in AT&T trial

The Justice Department's antitrust chief Makan Delrahim said on Thursday his "line is always open" if AT&T decides it wants to settle the case the government has brought to stop the telecom giant's acquisition of Time Warner......»»

Category: topSource: cnnApr 26th, 2018